Bringing the fundamentals into focus…
Back to BioCryst Pharmaceuticals, Inc.
How BioCryst Pharmaceuticals, Inc. stacks up
BCRX · against 588 other Healthcare companies listed in US-listed
Valuation
8/ 100
Near the bottom of its peers.
Ranked #313 of 589 · scores higher than 3% of peers
Bars: peers in each 10-point band of the valuation score277 peers with a valuation score of 0–9, including BCRX · Click a bar to see the companies
Why valuation scores 8?
Weighted metrics compared with all Healthcare companies.Mainly because of its earnings yield, which is weaker than most Healthcare peers.
- Negative (a loss or cash outflow), so it counts as zero whatever the share price. Earnings yield: -17.6% vs peer median 1.5%
- Negative (a loss or cash outflow), so it counts as zero whatever the share price. EBITDA yield: -14.2% vs peer median 4.0%
- more free cash flow for the price paid: stronger than 97% of peers. Free cash flow yield: 17.0% vs peer median 0.0%
Metric by metric
Position: dot = BCRX, ranked from the worst peer (left) to the best (right); tick = middle, shaded = middle half of peers.| Metric | BCRX | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Earnings yieldHigher is better · 577 reported | -16.3% | -4.3% | 26% | 30% | |
| EBITDA yieldHigher is better · 578 reported | 16.2% | -0.8% | 94% | 50% | |
| Free cash flow yieldHigher is better · 553 reported | 17.0% | -2.3% | 97% | 20% | |
| Book yieldHigher is better · 587 reported | -20.8% | 25.9% | 3% | Context only |
Ranking by valuation score
Top 5 and the companies ranked around BCRX| Rank | Company | Market cap | Valuation | Overall |
|---|---|---|---|---|
| 1 | 256M USD | 98 | 80 | |
| 2 | 595M USD | 96 | 97 | |
| 2 | 433M USD | 96 | 81 | |
| 2 | 289M USD | 96 | 57 | |
| 2 | 810M USD | 96 | 69 | |
| 313 | 7.3B USD | 8 | 32 | |
| 313 | 14.5B USD | 8 | 30 | |
| 313 | 815M USD | 8 | 53 | |
| 313 | 593M USD | 8 | 40 | |
| 313 | 2.2B USD | 8 | 32 | |
| 313 | 222M USD | 8 | 31 | |
| 313 | 2.7B USD | 8 | 50 | |
| 313 | 1.7B USD | 8 | 30 | |
| 313 | 2.4B USD | 8 | 6 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score